Rocket Lab (RKLB) Stock Falls 30% Despite Record Revenue and Nasdaq-100 Addition

Key Takeaways

• RKLB shares have declined approximately 30% from late-May highs, now hovering near $107.98
• First quarter revenue reached an all-time high of $200.35 million, representing a 63.4% year-over-year increase and surpassing analyst projections
• The company will be added to the Nasdaq-100 index on June 22, potentially increasing institutional buying pressure
• Institutional investors now hold 71.78% of shares, with Capital Impact Advisors increasing its position by 47.5%
• Analyst consensus shows a “Moderate Buy” rating with an average price target of $102.76

Since SpaceX’s highly anticipated public offering, Rocket Lab has experienced significant downward pressure, with shares declining roughly 30% from their late-May peak of approximately $151.00. Trading opened Thursday at $107.98, maintaining a position above the 50-day moving average of $104.00 while remaining considerably below recent peaks.

Rocket Lab USA, Inc., RKLB

The stock decline contrasts sharply with the company’s operational performance. First quarter revenue reached $200.35 million, establishing a new quarterly record and representing a robust 63.4% increase compared to the prior year period. This figure exceeded Wall Street’s consensus forecast of $189.65 million.

Gross profit margins also achieved a company record at 38.2% during Q1, demonstrating enhanced operational efficiency as the business expands. With a contract backlog totaling $2.2 billion, Rocket Lab maintains substantial revenue visibility extending well into future quarters.

Executive guidance indicates another record-breaking performance expected for Q2, extending a pattern that indicates the company is experiencing sustained growth momentum rather than temporary revenue spikes.

Government Contracts Expanding Revenue Streams

Beyond its core launch operations, Rocket Lab has been strategically expanding into defense sector opportunities. The company secured a substantial $515 million contract from the Space Development Agency in 2024 for satellite manufacturing, establishing Rocket Lab’s position as a primary contractor for U.S. government space initiatives.

Additionally, a $30 million agreement with Anduril Industries was finalized to deploy its HASTE launch vehicle for hypersonic testing missions from Virginia’s Launch Complex 2. These defense-oriented contracts are strategically diversifying the company’s revenue profile beyond traditional commercial small-satellite launch services.

The Electron rocket maintains its position as the globe’s most frequently launched small orbital vehicle, conducting approximately 10–15 missions annually. Its closest competitor in the small-launch market segment is Galactic Energy’s Ceres-1 rocket.

Recent developments include the announcement of the company’s largest block-purchase agreement to date — five Neutron rocket missions secured before the vehicle has completed its maiden flight.

Index Addition and Growing Institutional Ownership

Rocket Lab’s inclusion in the Nasdaq-100 index takes effect on June 22. This milestone represents a potentially significant catalyst, as index additions typically generate automatic purchasing activity from passive investment funds that track the benchmark.

Capital Impact Advisors expanded its holdings by 47.5% during the fourth quarter, acquiring an additional 145,741 shares to reach a total position of 452,728 units. Institutional investors collectively control 71.78% of outstanding shares.

Regarding insider transactions, SVP Arjun Kampani divested 23,804 shares at $147.43 on May 28, while insider Marvin Bradford Clevenger sold 3,500 shares at $146.67 during the same session. Company insiders have collectively sold $66.9 million in stock over the preceding 90-day period.

Valuation metrics present challenges for investors. The stock currently trades at a forward price-to-sales ratio of approximately 68x, exceeding the sector median by more than 3,500%. Such elevated multiples are generally associated with high-margin software enterprises rather than hardware-focused companies operating at 38% gross margins.

The Neutron medium-lift rocket, which appears to be significantly factored into current valuation levels, has yet to complete its inaugural launch. A recent propellant tank testing setback has delayed the maiden flight to Q4 2026, maintaining execution uncertainty.

TD Cowen and Needham both elevated their price objectives to $120 with Buy recommendations following the Q1 earnings release. KGI Securities launched coverage on June 11 with a Neutral stance and a $105 price target. The average analyst target currently stands at $102.76.

The post Rocket Lab (RKLB) Stock Falls 30% Despite Record Revenue and Nasdaq-100 Addition appeared first on Blockonomi.